Russia has become the first nation to complete clinical trials of Covid-19 vaccine on humans, and the results have proven the medication’s effectiveness.
The vaccine has been named “Sputnik V”, in reference to the first artificial satellite, Sputnik 1, which was launched by the USSR in 1957 – a sign that the Russian government plans to trumpet it as a matter of national pride.
The first batch of the Sputnik V vaccine for the prevention of the new corona virus infection, developed by the Gamaleya National Research Center of Epidemiology and Microbiology of the Ministry of Health of Russia, has passed the necessary quality tests in the laboratories of Roszdravnadzor (medical device regulator) and has been released into civil circulation.
The Vaccine was first registered by the Russian Ministry of Health on August 11. Moscow Mayor Sergey Sobyanin expressed hope on Sunday that the majority of the Russian capital’s residents will get vaccine against the coronavirus within several months.
The Clinical trails for Sputnik V will also be pushed by several other countries this month. Countries like India, Saudi Arabia, United Arab Emirates, Philippines, Brazil will begin their trail for Russian vaccine within this month.